May 13, 2026 Trump Administration Rushes to Name New FDA Commissioner Amid Makary’s Resignation and Policy Priorities
April 24, 2026 FDA Accelerates Review of Psychedelic Drugs for Mental Health with Priority Review Vouchers for Compass, Usona, and Transcend Therapeutics
